458 related articles for article (PubMed ID: 32725265)
1. Reduction of advanced tau-mediated memory deficits by the MAP kinase p38γ.
Ittner A; Asih PR; Tan ARP; Prikas E; Bertz J; Stefanoska K; Lin Y; Volkerling AM; Ke YD; Delerue F; Ittner LM
Acta Neuropathol; 2020 Sep; 140(3):279-294. PubMed ID: 32725265
[TBL] [Abstract][Full Text] [Related]
2. High Level Forebrain Expression of Active Tau Kinase p38γ Exacerbates Cognitive Dysfunction in Aged APP-transgenic Alzheimer's Mice.
Asih PR; Stefanoska K; Prikas E; Ittner A
Neuroscience; 2022 Feb; 484():53-65. PubMed ID: 35031398
[TBL] [Abstract][Full Text] [Related]
3. Isorhynchophylline ameliorates cognitive impairment via modulating amyloid pathology, tau hyperphosphorylation and neuroinflammation: Studies in a transgenic mouse model of Alzheimer's disease.
Li HQ; Ip SP; Yuan QJ; Zheng GQ; Tsim KKW; Dong TTX; Lin G; Han Y; Liu Y; Xian YF; Lin ZX
Brain Behav Immun; 2019 Nov; 82():264-278. PubMed ID: 31476414
[TBL] [Abstract][Full Text] [Related]
4. Site-specific phosphorylation of tau inhibits amyloid-β toxicity in Alzheimer's mice.
Ittner A; Chua SW; Bertz J; Volkerling A; van der Hoven J; Gladbach A; Przybyla M; Bi M; van Hummel A; Stevens CH; Ippati S; Suh LS; Macmillan A; Sutherland G; Kril JJ; Silva AP; Mackay JP; Poljak A; Delerue F; Ke YD; Ittner LM
Science; 2016 Nov; 354(6314):904-908. PubMed ID: 27856911
[TBL] [Abstract][Full Text] [Related]
5. Tau Protein Mediates APP Intracellular Domain (AICD)-Induced Alzheimer's-Like Pathological Features in Mice.
Ghosal K; Fan Q; Dawson HN; Pimplikar SW
PLoS One; 2016; 11(7):e0159435. PubMed ID: 27459671
[TBL] [Abstract][Full Text] [Related]
6. L-3-n-butylphthalide reduces tau phosphorylation and improves cognitive deficits in AβPP/PS1-Alzheimer's transgenic mice.
Peng Y; Hu Y; Xu S; Li P; Li J; Lu L; Yang H; Feng N; Wang L; Wang X
J Alzheimers Dis; 2012; 29(2):379-91. PubMed ID: 22233765
[TBL] [Abstract][Full Text] [Related]
7. A multifunctional therapeutic approach to disease modification in multiple familial mouse models and a novel sporadic model of Alzheimer's disease.
Luo J; Lee SH; VandeVrede L; Qin Z; Ben Aissa M; Larson J; Teich AF; Arancio O; D'Souza Y; Elharram A; Koster K; Tai LM; LaDu MJ; Bennett BM; Thatcher GR
Mol Neurodegener; 2016 Apr; 11():35. PubMed ID: 27129593
[TBL] [Abstract][Full Text] [Related]
8. Ca2+-permeable TRPV1 pain receptor knockout rescues memory deficits and reduces amyloid-β and tau in a mouse model of Alzheimer's disease.
Kim J; Lee S; Kim J; Ham S; Park JHY; Han S; Jung YK; Shim I; Han JS; Lee KW; Kim J
Hum Mol Genet; 2020 Jan; 29(2):228-237. PubMed ID: 31814000
[TBL] [Abstract][Full Text] [Related]
9. APP/Go protein Gβγ-complex signaling mediates Aβ degeneration and cognitive impairment in Alzheimer's disease models.
Bignante EA; Ponce NE; Heredia F; Musso J; Krawczyk MC; Millán J; Pigino GF; Inestrosa NC; Boccia MM; Lorenzo A
Neurobiol Aging; 2018 Apr; 64():44-57. PubMed ID: 29331876
[TBL] [Abstract][Full Text] [Related]
10. Propranolol reduces cognitive deficits, amyloid and tau pathology in Alzheimer's transgenic mice.
Dobarro M; Gerenu G; Ramírez MJ
Int J Neuropsychopharmacol; 2013 Nov; 16(10):2245-57. PubMed ID: 23768694
[TBL] [Abstract][Full Text] [Related]
11. Potassium 2-(1-hydroxypentyl)-benzoate improves memory deficits and attenuates amyloid and τ pathologies in a mouse model of Alzheimer's disease.
Peng Y; Hu Y; Xu S; Rong X; Li J; Li P; Wang L; Yang J; Wang X
J Pharmacol Exp Ther; 2014 Aug; 350(2):361-74. PubMed ID: 24893984
[TBL] [Abstract][Full Text] [Related]
12. Targeting CCR3 to Reduce Amyloid-β Production, Tau Hyperphosphorylation, and Synaptic Loss in a Mouse Model of Alzheimer's Disease.
Zhu C; Xu B; Sun X; Zhu Q; Sui Y
Mol Neurobiol; 2017 Dec; 54(10):7964-7978. PubMed ID: 27878757
[TBL] [Abstract][Full Text] [Related]
13. Ultrasound with microbubbles improves memory, ameliorates pathology and modulates hippocampal proteomic changes in a triple transgenic mouse model of Alzheimer's disease.
Shen Y; Hua L; Yeh CK; Shen L; Ying M; Zhang Z; Liu G; Li S; Chen S; Chen X; Yang X
Theranostics; 2020; 10(25):11794-11819. PubMed ID: 33052247
[TBL] [Abstract][Full Text] [Related]
14. Effects of CX3CR1 and Fractalkine Chemokines in Amyloid Beta Clearance and p-Tau Accumulation in Alzheimer's Disease (AD) Rodent Models: Is Fractalkine a Systemic Biomarker for AD?
Merino JJ; Muñetón-Gómez V; Alvárez MI; Toledano-Díaz A
Curr Alzheimer Res; 2016; 13(4):403-12. PubMed ID: 26567742
[TBL] [Abstract][Full Text] [Related]
15. CIP2A Causes Tau/APP Phosphorylation, Synaptopathy, and Memory Deficits in Alzheimer's Disease.
Shentu YP; Huo Y; Feng XL; Gilbert J; Zhang Q; Liuyang ZY; Wang XL; Wang G; Zhou H; Wang XC; Wang JZ; Lu YM; Westermarck J; Man HY; Liu R
Cell Rep; 2018 Jul; 24(3):713-723. PubMed ID: 30021167
[TBL] [Abstract][Full Text] [Related]
16. Neuronal deficiency of p38α-MAPK ameliorates symptoms and pathology of APP or Tau-transgenic Alzheimer's mouse models.
Schnöder L; Gasparoni G; Nordström K; Schottek A; Tomic I; Christmann A; Schäfer KH; Menger MD; Walter J; Fassbender K; Liu Y
FASEB J; 2020 Jul; 34(7):9628-9649. PubMed ID: 32475008
[TBL] [Abstract][Full Text] [Related]
17. CBP gene transfer increases BDNF levels and ameliorates learning and memory deficits in a mouse model of Alzheimer's disease.
Caccamo A; Maldonado MA; Bokov AF; Majumder S; Oddo S
Proc Natl Acad Sci U S A; 2010 Dec; 107(52):22687-92. PubMed ID: 21149712
[TBL] [Abstract][Full Text] [Related]
18. SLOH, a carbazole-based fluorophore, mitigates neuropathology and behavioral impairment in the triple-transgenic mouse model of Alzheimer's disease.
Wu X; Kosaraju J; Zhou W; Tam KY
Neuropharmacology; 2018 Mar; 131():351-363. PubMed ID: 29309769
[TBL] [Abstract][Full Text] [Related]
19. Abnormal interaction of VDAC1 with amyloid beta and phosphorylated tau causes mitochondrial dysfunction in Alzheimer's disease.
Manczak M; Reddy PH
Hum Mol Genet; 2012 Dec; 21(23):5131-46. PubMed ID: 22926141
[TBL] [Abstract][Full Text] [Related]
20. Orexin-A aggravates cognitive deficits in 3xTg-AD mice by exacerbating synaptic plasticity impairment and affecting amyloid β metabolism.
Li YY; Yu KY; Cui YJ; Wang ZJ; Cai HY; Cao JM; Wu MN
Neurobiol Aging; 2023 Apr; 124():71-84. PubMed ID: 36758468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]